CD274 and diffuse large B-cell lymphoma: Evasion of DLBCL immune surveillance is accomplished through various mechanisms, but PD-L1 (CD274) and PD-L2 (PDCD1LG2) dysregulation is one of the most notable from a therapeutic standpoint.